(Q53304769)

13 May 2018

title

Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors. (English)

1 reference

13 May 2018

0 references

1 reference

1

1 reference

13 May 2018

author name string

M Gagnon

series ordinal

2

1 reference

13 May 2018

publication date

25 September 2009

1 reference

13 May 2018

published in

Diabetologia

1 reference

13 May 2018

volume

52

1 reference

13 May 2018

page(s)

2471-2474

1 reference

13 May 2018

issue

12

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/s00125-009-1533-2

exact match

0 references

cites work

Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-009-1533-2

Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-009-1533-2

Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-009-1533-2

Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-009-1533-2

Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging

21 January 2018

1 reference

12 December 2020

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

1 reference

12 December 2020

Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes

1 reference

12 December 2020

Diabetes, Alzheimer's disease and apolipoprotein genotype

1 reference

12 December 2020

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study

1 reference

12 December 2020

Why is learning and memory dysfunction in Type 2 diabetes limited to older adults?

1 reference

12 December 2020

APOE genotype and cognitive decline in a middle-aged cohort

1 reference

12 December 2020

Insulin and neurodegenerative disease: shared and specific mechanisms

1 reference

12 December 2020

Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes.

1 reference

12 December 2020

Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis

1 reference

12 December 2020

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

1 reference

12 December 2020

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study

1 reference

12 December 2020

The role of apolipoprotein E in Alzheimer's disease

1 reference

12 December 2020

Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia.

1 reference

12 December 2020

The pathology of "vascular dementia": a critical update

1 reference

12 December 2020

Beta-amyloid deposition in brains of subjects with diabetes

1 reference

12 December 2020

Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study

1 reference

12 December 2020

Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.

1 reference

12 December 2020

10.1007/S00125-009-1533-2

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

19779694

1 reference

13 May 2018